(Q44218568)

30 November 2017

Pharmacokinetics of glyburide (English)

1 reference

30 November 2017

1 reference

J G Pearson

1

1 reference

PubMed ID

3931464

30 November 2017

language of work or name

English

0 references

publication date

1 September 1985

1 reference

American Journal of Medicine

30 November 2017

1 reference

30 November 2017

79

1 reference

30 November 2017

67-71

1 reference

30 November 2017

3B

1 reference

Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980010-3

The pharmacology of sulfonylureas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980010-3

Oral hypoglycaemic agents. An update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980010-3

Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980010-3

Specific and Sensitive High‐Performance Liquid Chromatographic Determination of Glyburide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980010-3

Determination of glyburide in human serum by liquid chromatography with fluorescence detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980010-3

High-performance liquid column and thin-layer chromatographic determination of human serum glibenclamide at therapeutic levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980010-3

Gas chromatographic determination of glibenclamide in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980010-3

Behaviour of glibenclamide on repeated administration to diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980010-3

Radioimmunoassay for Glyburide in Human Serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980010-3

Sulfonylurea treatment of insulin-independent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980010-3

Effect of sulfonylurea treatment on in vivo insulin secretion and action in patients with non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980010-3

The effect of chronic sulfonylurea therapy on hepatic glucose production in non-insulin-dependent diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980010-3

The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980010-3

Mechanism of improvement in glucose metabolism after chronic glyburide therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980010-3

Effect of chronic sulfonylurea therapy on plasma insulin and proinsulin levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980010-3

Effect of glipizide treatment on various aspects of glucose, insulin, and lipid metabolism in patients with noninsulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980010-3

Pharmacokinetics of intravenous glibenclamide investigated by a high performance liquid chromatographic assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980010-3

Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980010-3

Glibenclamide is exceptional among hypoglycaemic sulphonylureas in accumulating progressively in β-cell-rich pancreatic islets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980010-3

10.1016/S0002-9343(85)80010-3

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference

PubMed ID

3931464